Health Care Spending on Diabetes in the U.S., 1996–2013
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Health care spending on diabetes in the U.S. has increased dramatically over the past several decades. This research describes health care spending on diabetes to quantify how that spending has changed from 1996 to 2013 and to determine what drivers are increasing spending. RESEARCH DESIGN AND METHODS: Spending estimates were extracted from the Institute for Health Metrics and Evaluation’s Disease Expenditure 2013 database. Estimates were produced for each year from 1996 to 2013 for each of 38 age and sex groups and six types of care. Data on disease burden were extracted from the Global Burden of Disease 2016 study. We analyzed the drivers of spending by measuring the impact of population growth and aging and changes in diabetes prevalence, service utilization, and spending per encounter. RESULTS: Spending on diabetes in the U.S. increased from $37 billion (95% uncertainty interval $32–$42 billion) in 1996 to $101 billion ($97–$107 billion) in 2013. The greatest amount of health care spending on diabetes in 2013 occurred in prescribed retail pharmaceuticals (57.6% [53.8–62.1%] of spending growth) followed by ambulatory care (23.5% [21.7–25.7%]). Between 1996 and 2013, pharmaceutical spending increased by 327.0% (222.9–456.6%). This increase can be attributed to changes in demography, increased disease prevalence, increased service utilization, and, especially, increases in spending per encounter, which increased pharmaceutical spending by 144.0% (87.3–197.3%) between 1996 and 2013. CONCLUSIONS: Health care spending on diabetes in the U.S. has increased, and spending per encounter has been the biggest driver. This information can help policy makers who are attempting to control future spending on diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Economic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Boyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274 · cited 1×
“Diabetes in older adults is associatedwith higher mortality, decreased functional status, and a greater chance of both institutionalization and long-term complications (25),whicharecostly.”
BackgroundUS spending on personal health care and public health, 1996-2013.
Dieleman, J. L., Baral, R., Birger, M., Bui, A. L., Bulchis, A., Chapin, A., Hamavid, H., Horst, C., Johnson, E. K., Joseph, J., et al. (2016) · JAMA · doi:10.1001/jama.2016.16885 · Cited by 1,044 · cited 3×
“Among all conditions tracked in the DEXproject, diabetes incurred the greatest amount of spending in 2013 and increased the most between 1996 and 2013 (5).”
BackgroundMethodInfluentialSelf-citationImpact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602
Research works printed but not linked: 11
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, 2017, Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet, 390, 1211, 10.1016/S0140-6736(17)32154-2 · DOI · Paper page
- Dunn A, Liebman E, Shapiro AH. Decomposing medical-care expenditure growth [Internet], 2012. Available from http://www.frbsf.org/economic-research/files/wp12-26bk.pdf. Accessed 1 February 2017 · doi:10.3386/w23117
- Newhouse, 1993, An iconoclastic view of health cost containment, 152
- Smith, 2009, Income, insurance, and technology: why does health spending outpace economic growth, Health Aff (Millwood), 28, 1276, 10.1377/hlthaff.28.5.1276 · DOI · Paper page
- Starr, 2014, Decomposing growth in spending finds annual cost of treatment contributed most to spending growth, 1980-2006, Health Aff (Millwood), 33, 823, 10.1377/hlthaff.2013.0656 · DOI · Paper page
- Dieleman, 2017, Adjusting health spending for the presence of comorbidities: an application to United States national inpatient data, Health Econ Rev, 7, 30, 10.1186/s13561-017-0166-2 · DOI
- Flaxman, 2015, An Integrative Metaregression Framework for Descriptive Epidemiology
- Das Gupta, 1991, Decomposition of the difference between two rates and its consistency when more than two populations are involved, Math Popul Stud, 3, 105, 10.1080/08898489109525329 · DOI
- Hirshberg, 2013, Cardiovascular outcome studies with novel antidiabetes agents: scientific and operational considerations, Diabetes Care, 36, S253, 10.2337/dcS13-2041 · DOI
- Hua, 2016, Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013, JAMA, 315, 1400, 10.1001/jama.2016.0126 · DOI · Paper page
- Halter, 2012, Diabetes mellitus in an aging population: the challenge ahead, J Gerontol A Biol Sci Med Sci, 67, 1297, 10.1093/gerona/gls201 · DOI
Cited by
Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., Dalton, B. E., Duprey, J., Cruz, J. A., Hagins, H., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01301-6 · Cited by 6,146
US Health Care Spending by Payer and Health Condition, 1996-2016
Dieleman, J. L., Cao, J., Chapin, A., Chen, C., Li, Z., Liu, A., Horst, C., Kaldjian, A., Matyasz, T., Scott, K. W., et al. (2020) · JAMA · doi:10.1001/jama.2020.0734 · Cited by 1,313
Self-citationEconomic Costs of Diabetes in the U.S. in 2022
(2023) · doi:10.2337/dci23-0085 · Cited by 808
Caraballo, C., Valero-Elizondo, J., Khera, R., Mahajan, S., Grandhi, G. R., Virani, S. S., Mszar, R., Krumholz, H. M., & Nasir, K. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.119.006139 · Cited by 104
Metadata
- Authors
- Squires, E., Duber, H., Campbell, M., Cao, J., Chapin, A., Horst, C., Li, Z., Matyasz, T., Reynolds, A., Hirsch, I. B., & Dieleman, J. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2018-05-10
- Volume
- 41
- Issue
- 7
- Pages
- 1423-1431
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2801742794
- Cited by
- 40
- References
- 5
- FWCI
- 7.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- Funders
- The Peterson Center on Healthcare (16020)
- National Institute on Aging (P30-AG-047845)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Health Care Spending on Diabetes in the U.S., 1996–2013. https://app.cochat.ai/papers/10.2337/dc17-1376
- The paper
- Squires, E., Duber, H., Campbell, M., Cao, J., Chapin, A., Horst, C., Li, Z., Matyasz, T., Reynolds, A., Hirsch, I. B., & Dieleman, J. L. (2018). Health Care Spending on Diabetes in the U.S., 1996–2013. Diabetes Care. https://doi.org/10.2337/dc17-1376
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.